---
figid: PMC5788694__oncotarget-09-2931-g004
figtitle: Role of ginsenosides in reactive oxygen species-mediated anticancer therapy
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5788694
filename: oncotarget-09-2931-g004.jpg
figlink: /pmc/articles/PMC5788694/figure/F4/
number: F4
caption: Ginsenoside activate estrogen receptor 2 (ESR2)-neutrophil cytosolic factor
  1 (NCF1)-ROS signaling pathway. ROS then activate JNK which in turns phosphorylate
  Bcl-2 and release Beclin 1 and induce autophagy through up-regulation of ATG5, Atg7,
  LC3-I and LC3-II. →, Activation; ┤, Inhibition.
papertitle: Role of ginsenosides in reactive oxygen species-mediated anticancer therapy.
reftext: Islam M.D. Sodrul, et al. Oncotarget. 2018 Jan 5;9(2):2931-2950.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9452621
figid_alias: PMC5788694__F4
figtype: Figure
redirect_from: /figures/PMC5788694__F4
ndex: d8b74409-defe-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5788694__oncotarget-09-2931-g004.html
  '@type': Dataset
  description: Ginsenoside activate estrogen receptor 2 (ESR2)-neutrophil cytosolic
    factor 1 (NCF1)-ROS signaling pathway. ROS then activate JNK which in turns phosphorylate
    Bcl-2 and release Beclin 1 and induce autophagy through up-regulation of ATG5,
    Atg7, LC3-I and LC3-II. →, Activation; ┤, Inhibition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ESR2
  - NCF1
  - CYBB
  - DECR1
  - BECN1
  - MAPK8
  - MAPK9
  - MAPK10
  - MTOR
  - ATG5
  - ATG7
  - ATG3
  - Rapamycin
  - Ginsenosides
---
